Genomic Valley Biotech Ltd vs Pe Analytics Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Mar 14, 2026

Key Highlights

The Latest Trading Price of Genomic Valley Biotech Ltd is ₹ 24.99 as of 13 Mar 15:30 . The P/E Ratio of Genomic Valley Biotech Ltd changed from 0 on March 2022 to 0 on March 2025 . This represents a CAGR of 0.0% over 4 yearsThe P/E Ratio of P.E. Analytics Ltd changed from 15.3 on March 2023 to 18.5 on March 2025 . This represents a CAGR of 6.54% over 3 years The Market Cap of Genomic Valley Biotech Ltd changed from ₹ 0 crore on March 2022 to ₹ 0 crore on March 2025 . This represents a CAGR of 0.0% over 4 yearsThe Market Cap of P.E. Analytics Ltd changed from ₹ 157.6 crore on March 2023 to ₹ 238.99 crore on March 2025 . This represents a CAGR of 14.89% over 3 years The revenue of Genomic Valley Biotech Ltd for the Dec '25 is ₹ 0.05 crore as compare to the Sep '25 revenue of ₹ 0.09 crore. This represent the decline of -44.44% The revenue of P.E. Analytics Ltd for the Dec '25 is ₹ 0 crore as compare to the Sep '25 revenue of ₹ 0 crore. This represent the decline of 0% The ebitda of Genomic Valley Biotech Ltd for the Dec '25 is ₹ 0.01 crore as compare to the Sep '25 ebitda of ₹ 0 crore. This represent the growth of 9.2233718E16% The ebitda of P.E. Analytics Ltd for the Dec '25 is ₹ 0 crore as compare to the Sep '25 ebitda of ₹ 0 crore. This represent the decline of 0% The net profit of Genomic Valley Biotech Ltd changed from ₹ 0.13 crore to ₹ 0.01 crore over 7 quarters. This represents a CAGR of -76.91% The net profit of P.E. Analytics Ltd changed from ₹ 0 crore to ₹ 0 crore over 7 quarters. This represents a CAGR of 0.0% The Dividend Payout of Genomic Valley Biotech Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Dividend Payout of P.E. Analytics Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 years .

About Genomic Valley Biotech Ltd

Incorporated in May 1994, Genomic Valley Biotech Limited is formed with the objective of conducting research in the field of Biotechnology (Plant & Animal) and also to undertake commercial production of Plant Tissue Cultured Plants of different species to feed the genetically improved plant market nationally as well as internationally.
The Company is extensively involved in commercial greenhouse / poly house cultivation of crops.
Presently, it is engaged in high-tech cultivation through environmental controlled Poly Houses,NFT & DFT etc,manufacturing of Tissue Cultured Improved variety of plants and organic farming using Bio-Fertilizer.
Also it is involved in commercial Horticulture activities with Aloe vera, Tomato, Bitter Gourd, Bottle Gourd, Brinjal, Broccoli, Cabbage, Capsicum, Carrot, Cauliflower, Cucumber, Green Chillies, Onion, Radish, Ridge/Sponge Gourd, Leafy Vegetables, Pumpkin, Banana, Guava, Papaya, and Strawberry.

About P.E. Analytics Ltd

P.E. Analytics Limited was incorporated on January 08, 2008 as a Private Company with the Registrar of Companies, Delhi as P. E. Analytics Private Limited'.
Subsequently, the status of the Company got converted into Public Company and fresh Certificate of Incorporation dated February 08, 2022 was issued to the Company by the Registrar of Companies, Delhi. PropEquity is India's largest Real Estate Data & Analytics company and listed on the NSE Stock Exchange as P.E. Analytics Limited.
PropEquity was founded on a visionary premise to address the challenges of large investments in an unstructured & opaque real estate environment that lacked realtime data. The Company is engaged in providing proprietary Real Estate Business Intelligence and Analytics platform on B2B business model to various users such as developers, construction industry, investors, banks, housing finance companies, equity research firms, real estate PE funds, REIT's, financial institutions, Mortgage Insurers, HNIs, Lenders and Investors in real estate.

FAQs for the comparison of Genomic Valley Biotech Ltd and P.E. Analytics Ltd

Which company has a larger market capitalization, Genomic Valley Biotech Ltd or P.E. Analytics Ltd?

Market cap of Genomic Valley Biotech Ltd is 7 Cr while Market cap of P.E. Analytics Ltd is 199 Cr

What are the key factors driving the stock performance of Genomic Valley Biotech Ltd and P.E. Analytics Ltd?

The stock performance of Genomic Valley Biotech Ltd and P.E. Analytics Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Genomic Valley Biotech Ltd and P.E. Analytics Ltd?

As of March 14, 2026, the Genomic Valley Biotech Ltd stock price is INR ₹24.99. On the other hand, P.E. Analytics Ltd stock price is INR ₹189.9.

How do dividend payouts of Genomic Valley Biotech Ltd and P.E. Analytics Ltd compare?

To compare the dividend payouts of Genomic Valley Biotech Ltd and P.E. Analytics Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.